Clinical trial No longer in our active list Phase 4 Interventional Ages 18 and up

Intranasal sufentanil for treating acute post-traumatic pain in emergency patients

Official title: The Effect of Intranasal Sufentanil on Acute Posttraumatic Pain. A Randomized Study.

Run by Centre Hospitalier Universitaire Saint Pierre · NCT04137198 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if a nasal spray of sufentanil can help people with severe pain after an injury feel better compared to just the usual pain treatment they receive in the emergency room.

More Analgesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorCentre Hospitalier Universitaire Saint Pierre
Academic / other
Locations1 site (Bruxelles)
Trial IDNCT04137198 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults presenting with acute post-traumatic pain lasting less than 24 hours and rated 7 or higher on the pain scale.

Probably not a fit

Patients who may not benefit include those with chronic pain conditions, significant comorbidities, or contraindications to opioid use.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of intranasal sufentanil in patients who arrive at the emergency department with acute post-traumatic pain rated 7 or higher on a visual analog scale. Participants are randomly assigned to either a control group receiving standard analgesic treatment or an intervention group receiving standard treatment plus intranasal sufentanil. Pain levels are assessed at 15-20 minutes and 60 minutes post-administration, along with monitoring for any adverse effects and vital signs. The goal is to determine if intranasal sufentanil provides superior pain relief compared to standard care alone.

Why it matters

Potential benefit: If successful, this approach could offer a more effective and rapid pain relief option for patients experiencing acute post-traumatic pain in emergency settings.

How similar studies have gone: Other studies have shown promising results with intranasal opioids for pain management, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* posttraumatic pain + lasting for less than 24 hours + with an analog visual pain scale of 7/10 or more

Exclusion Criteria:

* pregnant
* \<18 years
* prisoners
* lesions of head, face or abdomen
* no consent given or possible
* pain not scorable
* known drug abuse or substitution therapy
* chronic level 3 pain medication
* intake of level 3 \< 8 hours
* intoxicated patient
* allergy or intolerance to opiates
* renal or hepatic insufficiency
* \< 50kg body weight
* hemodynamic instability

Where it's running

  • CHU Saint Pierre
    Bruxelles, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.